bioTheranostics’ Prostate Cancer Index Predicts Risk for Prostate Cancer Recurrence
Study demonstrates clinical validity of new molecular test, which stratifies risk of PSA recurrence and metastasis.
Read More
Search Results for: prostate cancer
Experts Discuss Role of Molecular Biomarkers in Diagnosis and Staging of Prostate Cancer
The ConfirmMDx test from MDx Health helps urologists rule out prostate cancer-free men from undergoing unnecessary repeat biopsies.
Read More
European Launch of Myriad’s MDx Prolaris, Predictor of Prostate Cancer Recurrence
It is a 46-gene prognostic test that offers urologists a more accurate way to determine the aggressiveness of prostate cancer.
Read MoreGenomeDx Decipher Test for Prostate Cancer Predicts Metastasis, Impacts Treatment Decisions
It measures the expression levels of multiple markers associated with aggressive prostate cancer and provides additional information about a patient’s risk of disease progression after surgery.
Read More
Ventana, Biocare Medical Partner to Aid in Differential Diagnosis of Prostate Cancer
Including p63 in Biocare’s lung, prostate, and breast panels empowers its Multiplex IHC platform to aid pathologists in making critical decisions.
Read More